Barriers to recruiting underrepresented populations to cancer clinical trials: A systematic review

Cancer

Volumn 112, Issue 2, 2008, Pages 228-242

  Ford, Jean G ^a,b   Howerton, Mollie W ^b   Lai, Gabriel Y ^a   Gary, Tiffany L ^a   Bolen, Shari ^b,c,d   Gibbons, M Chris ^c   Tilburt, Jon ^b,c,d   Baffi, Charles ^e   Tanpitukpongse, Teerath Peter ^b,c,d   Wilson, Renee F ^d   Powe, Neil R ^b,c,d   Bass, Eric B ^b,c,d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Clinical trials; Health disparities; Racial ethnic minority populations; Recruitment; Systematic review; Underrepresented populations

Indexed keywords

CANCER PREVENTION; CANCER RESEARCH; CANCER THERAPY; DATA BASE; EVIDENCE BASED PRACTICE; HUMAN; INFORMATION PROCESSING; MINORITY GROUP; OUTCOMES RESEARCH; PATIENT SELECTION; POPULATION RESEARCH; PRIORITY JOURNAL; PUBLICATION; RACE DIFFERENCE; RELIABILITY; REVIEW; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; VALIDITY;

CLINICAL TRIALS AS TOPIC; CULTURE; HUMANS; LANGUAGE; MINORITY GROUPS; NEOPLASMS; PATIENT SELECTION; RESEARCH DESIGN;

EID: 38049065363     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23157     Document Type: Review

References (88)

1. Institute of Medicine. The Unequal Burden of Cancer: An Assessment of NIH Research and Programs for Ethnic Minorities and the Medically Underserved. Washington, DC: National Academy Press; 1999.
2. National Institute of Health. Monitoring Adherence to the NIH Policy on the Inclusion of Women and Minorities as Subjects in Clinical Research. Available at URL: http://www4.od.nih.gov/orwh/GoldReport_2000-01.pdf Accessed October 1, 2004.
3. National Institute of Health. NIH Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research - amended October, 2001. Available at URL: http://grants.nih.gov/grants/funding/women_min/ guidelines_amended_10_2001.htm Accessed October 1, 2004.
4. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94:334-357.
5. Sateren WB, Trimble EL, Abrams J, et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol. 2002;20:2109-2117.
6. Swanson GM, Bailar JC 3rd. Selection and description of cancer clinical trials participants - science or happenstance? Cancer. 2002;95:950-959.
7. Moser M, Lunn J. Responses to Captopril and hydrochlorothiazide in black patients with hypertension. Clin Pharmacol Ther. 1982;32:307-312.
8. Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA. 2000;283:2701-2711.
9. Tejeda HA, Green SB, Trimble EL, et al. Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst. 1996;88:812-816.
10. Outlaw FH, Bourjolly JN, Barg FK. A study on recruitment of black Americans into clinical trials through a cultural competence lens. Cancer Nurs. 2000;23:444-451; quiz 451-442.
11. Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999;341:1198-1205.
12. Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL. Primary care physicians who treat blacks and whites. N Engl J Med. 2004;351:575-584.
13. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002;287:2106-2113.
14. Powe NR, Gary TL. Race and research in focus: perspectives on minority participation. In: Bettina M, ed. Health Studies: Clinical Trials. Washington, DC: American Public Health Association; 2004.
15. Ford JG, Howerton MW, Bolen S, et al. Evidence Report on Knowledge and Access to Information on Recruitment of Underrepresented Populations to Cancer Clinical Trials. Evidence Report/Technology Assessment No 05-E019-2 ed. Baltimore, Md: Johns Hopkins University Evidence-based Practice Center; 2005.
16. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490-1497.
17. Adams-Campbell LL, Ahaghotu C, Gaskins M, et al. Enrollment of African Americans onto clinical treatment trials: study design barriers. J Clin Oncol. 2004;22:730-734.
18. Advani AS, Atkeson B, Brown CL, et al. Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study. Cancer. 2003;97:1499-1506.
19. Bailey JM, Bieniasz ME, Kmak D, Brenner DE, Ruffin MT. Recruitment and retention of economically underserved women to a cervical cancer prevention trial. Appl Nurs Res. 2004;17:55-60.
20. Barofsky I, Sugarbaker PH. Determinants of patient non-participation in randomized clinical trials for the treatment of sarcomas. Cancer Clin Trials. 1979;2:237-246.
21. Berman BA, Grosser SC, Gritz ER. Recruitment to a school-based adult smoking-cessation program: do gender and race/ethnicity make a difference? J Cancer Educ. 1998;13: 220-225.
22. Bieniasz ME, Underwood D, Bailey J, Ruffin MT 4th. Women's feedback on a chemopreventive trial for cervical dysplasia. Appl Nurs Res. 2003;16:22-28.
23. Brewster WR, Anton-Culver H, Ziogas A, et al. Recruitment strategies for cervical cancer prevention study. Gynecol Oncol. 2002;85:250-254.
24. Broome ME, Richards DJ, Hall JM. Children in research: the experience of ill children and adolescents. J Fam Nurs. 2001;7:32-49.
25. Broome ME, Richards DJ. The influence of relationships on children's and adolescents' participation in research. Nurs Res. 2003;52:191-197.
26. Brown DR, Fouad MN, Basen-Engquist K, Tortolero-Luna G. Recruitment and retention of minority women in cancer screening, prevention, and treatment trials. Ann Epidemiol. 2000;10(8 suppl):S13-S21.
27. Brown DR, Topcu M. Willingness to participate in clinical treatment research among older African Americans and whites. Gerontologist. 2003;43:62-72.
28. Chen CI, Skingley P, Meyer RM. A comparison of elderly patients with aggressive histology lymphoma who were entered or not entered on to a randomized phase II trial. Leuk Lymphoma. 2000;38(3-4):327-334.
29. Comis RL, Miller JD, Aldige CR, Krebs L, Stoval E. Public attitudes toward participation in cancer clinical trials. J Clin Oncol. 2003;21:830-835.
30. Cook ED, Moody-Thomas S, Anderson KB, et al. Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Clin Trials. 2005;2:436-442.
31. Diener-West M, Earle JD, Fine SL, et al. Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: characteristics of patients enrolled and not enrolled. COMS Report No. 17. Arch Ophthalmol. 2001;119:951-965.
32. Ellington L, Wahab S, Sahami Martin S, Field R, Mooney KH. Factors that influence Spanish- and English-speaking participants' decision to enroll in cancer randomized clinical trials. Psychooncology. 2006;15:273-284.
33. Ford ME, Havstad SL, Davis SD. A randomized trial of recruitment methods for older African American men in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Clin Trials. 2004;1:343-351.
34. Fouad MN, Partridge E, Green BL, et al. Minority recruitment in clinical trials: a conference at Tuskegee, researchers and the community. Ann Epidemiol. 2000;10(8 suppl): S35-S40.
35. Grann VR, Jacobson JS, Troxel AB, et al. Barriers to minority participation in breast carcinoma prevention trials. Cancer. 2005;104:374-379.
36. Green BL, Partridge EE, Fouad MN, Kohler C, Crayton EF, Alexander L. African-American attitudes regarding cancer clinical trials and research studies: results from focus group methodology. Ethnic Dis. 2000;10:76-86.
37. Gross CP, Herrin J, Wong N, Krumholz HM. Enrolling older persons in cancer trials: the effect of sociodemographic, protocol, and recruitment center characteristics. J Clin Oncol. 2005;23:4755-4763.
38. Gross CP, Krumholz HM. Impact of managed care on cancer trial enrollment. J Clin Oncol. 2005;23:3811-3818.
39. Gross CP, Wong N, Dubin JA, Mayne ST, Krumholz HM. Enrollment of older persons in cancer trials after the Medicare reimbursement policy change. Arch Intern Med. 2005; 165:1514-1520.
40. Gross CP, Filardo G, Mayne ST, Krumholz HM. The impact of socioeconomic status and race on trial participation for older women with breast cancer. Cancer. 2005;103:483-491.
41. Grunfeld E, Zitzelsberger L, Coristine M, Aspelund F. Barriers and facilitators to enrollment in cancer clinical trials: qualitative study of the perspectives of clinical research associates. Cancer. 2002;95:1577-1583.
42. Hunter CP, Frelick RW, Feldman AR, et al. Selection factors in clinical trials: results from the Community Clinical Oncology Program Physician's Patient Log. Cancer Treat Rep. 1987;71:559-565.
43. Jatoi A, Hillman S, Stella P, et al. North Central Cancer Treatment Group. Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. J Clin Oncol. 2005;23:9113-9119.
44. Kaluzny A, Brawley O, Garson-Angert D, et al. Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program. J Natl Cancer Inst. 1993;85:1945-1950.
45. Kemeny MM, Peterson BL, Kornblith AB, et al. Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol. 2003;21:2268-2275.
46. Kemp N, Skinner E, Toms J. Randomized clinical trials of cancer treatment - a public opinion survey. Clin Oncol. 1984;10:155-161.
47. Kimmick GG, Peterson BL, Kornblith AB, et al. Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001. J Clin Oncol. 2005; 23:2201-2207.
48. Kornblith AB, Kemeny M, Peterson BL, et al. Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials. Cancer. 2002;95:989-996.
49. Krailo MD, Bernstein L, Sullivan-Halley J, Hammond GD. Patterns of enrollment on cooperative group studies. An analysis of trends from the Los Angeles County Cancer Surveillance Program. Cancer. 1993;71(10 suppl):3325-3330.
50. Lara PN Jr, Higdon R, Lim N, et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol. 2001;19:1728-1733.
51. Lara PN Jr, Paterniti DA, Chiechi C, et al. Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. J Clin Oncol. 2005;23:9282-9289.
52. Lee MM, Chamberlain RM, Catchatourian R, et al. Social factors affecting interest in participating in a prostate cancer chemoprevention trial. J Cancer Educ. 1999;14:88-92.
53. Lerman C, Rimer BK, Daly M, et al. Recruiting high risk women into a breast cancer health promotion trial. Cancer Epidemiol Biomarkers Prev. 1994;3:271-276.
54. Lewis JH, Kilgore ML, Goldman DP, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol. 2003;21:1383-1389.
55. Ling J, Rees E, Hardy J. What influences participation in clinical trials in palliative care in a cancer centre? Eur J Cancer. 2000;36:621-626.
56. Mandelblatt J, Kaufman E, Sheppard VB, et al. Breast cancer prevention in community clinics: will low-income Latina patients participate in clinical trials? Prev Med. 2005;40:611-618.
57. Martel CL, Li Y, Beckett L, et al. An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California. Cancer J. 2004;10:294-300.
58. McCaskill-Stevens W, Pinto H, Marcus AC, et al. Recruiting minority cancer patients into cancer clinical trials: a pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association. J Clin Oncol. 1999; 17:1029-1039.
59. Melisko ME, Hassin F, Metzroth L, et al. Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers. Clin Breast Cancer. 2005;6:45-54.
60. Millon-Underwood S, Sanders E, Davis M. Determinants of participation in state-of-the-art cancer prevention, early detection/screening, and treatment trials among African-Americans. Cancer Nurs. 1993;16:25-33.
61. Moinpour CM, Atkinson JO, Thomas SM, et al. Minority recruitment in the prostate cancer prevention trial. Ann Epidemiol. 2000;10(8 suppl):S85-S91.
62. Mouton CP, Harris S, Rovi S, Solorzano P, Johnson MS. Barriers to black women's participation in cancer clinical trials. J Natl Med Assoc. 1997;89:721-727.
63. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004;291:2720-2726.
64. Paskett ED, Cooper MR, Stark N, et al. Clinical trial enrollment of rural patients with cancer. Cancer Pract. 2002;10: 28-35.
65. Paterniti DA, Chen MS Jr, Chiechi C, et al. Asian Americans and cancer clinical trials: a mixed-methods approach to understanding awareness and experience. Cancer. 2005; 104(12 suppl):3015-3024.
66. Pinto HA, McCaskill-Stevens W, Wolfe P, Marcus AC. Physician perspectives on increasing minorities in cancer clinical trials: an Eastern Cooperative Oncology Group (ECOG) Initiative. Ann Epidemiol. 2000;10(8 suppl):S78-S84.
67. Randall-David B, Stark N, Gierisch J, Torti F. 'What do they know about it?' How the North Carolina public views cancer clinical trials: implications for primary care doctors. N C Med J. 2001;62:281-285.
68. Roberson NL. Clinical trial participation. Viewpoints from racial/ethnic groups. Cancer. 1994;74(9 suppl):2687-2691.
69. Robinson SB, Ashley M, Haynes MA. Attitude of African-Americans regarding prostate cancer clinical trials. J Commun Health. 1996;21:77-87.
70. Sears SR, Stanton AL, Kwan L, et al. Recruitment and retention challenges in breast cancer survivorship research: results from a multisite, randomized intervention trial in women with early stage breast cancer. Cancer Epidemiol Biomarkers Prev. 2003;12:1087-1090.
71. Simon MS, Du W, Flaherty L, et al. Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center. J Clin Oncol. 2004;22:2046-2052.
72. Spaight SJ, Nash S, Finison LJ, Patterson WB. Medical oncologists' participation in cancer clinical trials. Prog Clin Biol Res. 1984;156:49-61.
73. Tercyak KP, Donze JR, Prahlad S, Mosher RB, Shad AT. Identifying, recruiting, and enrolling adolescent survivors of childhood cancer into a randomized controlled trial of health promotion: preliminary experiences in the Survivor Health and Resilience Education (SHARE) Program. J Pediatr Psychol. 2006;31:252-261.
74. Thornquist MD, Patrick DL, Omenn GS. Participation and adherence among older men and women recruited to the Beta-Carotene and Retinol Efficacy Trial (CARET). Gerontologist. 1991;31:593-597.
75. Trauth JM, Jernigan JC, Siminoff LA, Musa D, Neal-Ferguson D, Weissfeld J. Factors affecting older African American women's decisions to join the PLCO Cancer Screening Trial. J Clin Oncol. 2005;23:8730-8738.
76. Twelves CJ, Thomson CS, Young J, Gould A. Entry into clinical trials in breast cancer: the importance of specialist teams. Scottish Breast Cancer Focus Group and Scottish Cancer Therapy Network. Eur J Cancer. 1998;34:1004-1007.
77. Woods MN, Harris KJ, Mayo MS, Catley D, Scheibmeir M, Ahluwalia JS. Participation of African Americans in a smoking cessation trial: a quantitative and qualitative study. J Natl Med Assoc. 2002;94:609-618.
78. Howerton MW, Gibbons MC, Baffi CR, et al. Provider roles in the recruitment of underrepresented populations to cancer clinical trials. Cancer. 2007;109:465-476.
79. el-Sadr W, Capps L. The challenge of minority recruitment in clinical trials for AIDS. JAMA. 1992;267:954-957.
80. Somkin CP, Altschuler A, Ackerson L, et al. Organizational barriers to physician participation in cancer clinical trials. Am J Manag Care. 2005;11:413-421.
81. Freeman HP. The impact of clinical trial protocols on patient care systems in a large city hospital. Access for the socially disadvantaged. Cancer. 1993;72(9 suppl):2834-2838.
82. Lawrence W Jr, Antman K, Freeman HP, et al. The impact of clinical trial protocols on patient care systems. Cancer. 1993:72(9 suppl):2839-2841.
83. Fouad MN, Partridge E, Wynn T, Green BL, Kohler C, Nagy S. Statewide Tuskegee Alliance for Clinical Trials. A community coalition to enhance minority participation in medical research. Cancer. 2001;91(1 suppl):237-241.
84. Nguyen TT, Somkin CP, Ma Y. Participation of Asian-American women in cancer chemoprevention research: physician perspectives. Cancer. 2005;104(12 suppl):3006-3014.
85. Ard JD, Durant RW, Edwards LC, Svetkey LP. Perceptions of African-American culture and implications for clinical trial design. Ethnic Dis. 2005;15:292-299.
86. Corbie-Smith G, Thomas SB, Williams MV, Moody-Ayers S. Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med. 1999;14:537-546.
87. Lai GY, Gary TL, Tilburt J, et al. Effectiveness of strategies to recruit underrepresented populations into cancer clinical trials. Clin Trials. 2006;3:133-141.
88. Fouad MN, Corbie-Smith G, Curb D, et al. Special populations recruitment for the Women's Health Initiative: successes and limitations. Control Clin Trials. 2004;25:335-352.